Rohit Gupta, President and CEO of Enact Holdings, Inc., filed a Form 4 on September 21, 2026, disclosing the acquisition of restricted stock units through dividend reinvestment on September 17, 2026.
Mitchell Hardin Dean, EVP, CFO and Treasurer of Enact Holdings, Inc. (NASDAQ:ACT), filed a Form 4 on September 21, 2026, disclosing the acquisition of restricted stock units on September 17, 2026, resulting from quarterly dividend reinvestment.
A Statement of Changes in Beneficial Ownership was filed on September 21, 2026, disclosing that Enact Holdings, Inc. director Robert P. Restrepo Jr. acquired 177 Deferred Stock Units through dividend reinvestment on September 17, 2026.
A Form 4 filed on September 21, 2026, with the U.S. Securities and Exchange Commission reported that Dominic James Addesso, Director and Chairperson of the Board of Enact Holdings, Inc. (NASDAQ:ACT), acquired 308 Deferred Stock Units on September 17, 2026, through dividend reinvestment under …
WW International, Inc. filed an amended current report on September 21, 2026, confirming that Stephen J. Bye will begin his role as President and Chief Executive Officer on October 1, 2026, following a mutual agreement reached on September 18, 2026.
Spruce Power Holding Corporation filed an amended Form 8-K/A on September 21, 2026, disclosing that the contingencies to director Clara Nagy McBane's resignation were satisfied on September 18, 2026, and that Benjamin Rosenzweig was appointed to the Board effective the same date.
BancFirst Corporation filed a current report on September 21, 2026, disclosing that its Board of Directors declared a quarterly cash dividend on common stock and announced an interest payment on its Junior Subordinated Debentures related to BFC Capital Trust II.
TechPrecision Corporation filed a current report with the SEC on September 21, 2026, disclosing that its wholly owned subsidiary Ranor, Inc. and affiliated borrowers entered into an amendment extending the maturity date of a revolving line of credit with Beacon Bank & Trust.
Electra Therapeutics, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on September 21, 2026, reporting the closing of its initial public offering and the adoption of amended and restated governance documents effective the same date.
Credit Acceptance Corporation filed an 8-K on September 21, 2026, disclosing amendments to two asset-backed financing facilities, both executed on September 15, 2026, with Wells Fargo Bank, National Association serving as a counterparty on each.